Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin vs Ivermectin in Onchocerciasis
NCT00790998Phase 3Completed
- Sponsor
- Medicines Development for Global Health
- Start
- Apr 2009
- Primary completion
- Feb 2012
- Modality
- Allosteric Modulators
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of moxidectin in onchocerciasis (2 arms), sponsored by Medicines Development for Global Health. Primary endpoint: Skin microfilaria density at 12 months. Started Apr 2009; status: completed.
02
Drugs
moxidectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT00790998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790998.